Join
Live feed
·
INSIDERFilingvia Quantisnow
T2 Biosystems Inc. logo

SEC Form 4: Gibbs Michael Terrence converted options into 6,914 shares and sold $2,329 worth of shares (3,730 units at $0.62) as part of a pre-agreed trading plan, increasing direct ownership by 96% to 6,517 units

ByQuantisnow·Wall Street's wire, on your screen.
TTOO· T2 Biosystems Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TTOO (T2 Biosystems Inc.) and more on Quantisnow.

SEC Form 4: Gibbs Michael Terrence converted options into 6,914 shares and sold $2,329 worth of shares (3,730 units at $0.62) as part of a pre-agreed trading plan, increasing direct ownership by 96% to 6,517 units | Quantisnow